Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma
Osteosarcoma (OS), frequently observed in children and adolescents, is one of the most common primary malignant tumors of the bone known to be associated with a high capacity for invasion and metastasis. The incidence of osteosarcoma in children and adolescents is growing annually, although improvem...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-07-01
|
| Series: | Genes and Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304224001326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849723166237130752 |
|---|---|
| author | Xianglin Peng Jing Feng Han Yang Ping Xia Feifei Pu |
| author_facet | Xianglin Peng Jing Feng Han Yang Ping Xia Feifei Pu |
| author_sort | Xianglin Peng |
| collection | DOAJ |
| description | Osteosarcoma (OS), frequently observed in children and adolescents, is one of the most common primary malignant tumors of the bone known to be associated with a high capacity for invasion and metastasis. The incidence of osteosarcoma in children and adolescents is growing annually, although improvements in survival remain limited. With the clinical application of neoadjuvant chemotherapy, chemotherapy combined with limb-preserving surgery has gained momentum as a major intervention. However, certain patients with OS experience treatment failure owing to chemoradiotherapy resistance or metastasis. Nuclear factor E2-related factor 2 (Nrf2), a key antioxidant factor in organisms, plays a crucial role in maintaining cellular physiological homeostasis; however, its overactivation in cancer cells restricts reactive oxygen species production, promotes DNA repair and drug efflux, and ultimately leads to chemoradiotherapy resistance. Recent studies have also identified the functions of Nrf2 beyond its antioxidative function, including the promotion of proliferation, metastasis, and regulation of metabolism. The current review describes the multiple mechanisms of chemoradiotherapy resistance in OS and the substantial role of Nrf2 in the signaling regulatory network to elucidate the function of Nrf2 in promoting OS chemoradiotherapy resistance and formulating relevant therapeutic strategies. |
| format | Article |
| id | doaj-art-cd07e9b9f92d4e66a7f647efbf1e563d |
| institution | DOAJ |
| issn | 2352-3042 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Genes and Diseases |
| spelling | doaj-art-cd07e9b9f92d4e66a7f647efbf1e563d2025-08-20T03:11:06ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422025-07-0112410133510.1016/j.gendis.2024.101335Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcomaXianglin Peng0Jing Feng1Han Yang2Ping Xia3Feifei Pu4Department of Orthopedics, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan 430022, ChinaDepartment of Orthopedics, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan 430022, ChinaSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China; Department of Immunology, Zunyi Medical University, Zunyi 563000, ChinaDepartment of Orthopedics, Wuhan Fourth Hospital, Wuhan 430030, China; Corresponding author.Department of Orthopedics, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan 430022, China; Corresponding author. Department of Orthopedics, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.Osteosarcoma (OS), frequently observed in children and adolescents, is one of the most common primary malignant tumors of the bone known to be associated with a high capacity for invasion and metastasis. The incidence of osteosarcoma in children and adolescents is growing annually, although improvements in survival remain limited. With the clinical application of neoadjuvant chemotherapy, chemotherapy combined with limb-preserving surgery has gained momentum as a major intervention. However, certain patients with OS experience treatment failure owing to chemoradiotherapy resistance or metastasis. Nuclear factor E2-related factor 2 (Nrf2), a key antioxidant factor in organisms, plays a crucial role in maintaining cellular physiological homeostasis; however, its overactivation in cancer cells restricts reactive oxygen species production, promotes DNA repair and drug efflux, and ultimately leads to chemoradiotherapy resistance. Recent studies have also identified the functions of Nrf2 beyond its antioxidative function, including the promotion of proliferation, metastasis, and regulation of metabolism. The current review describes the multiple mechanisms of chemoradiotherapy resistance in OS and the substantial role of Nrf2 in the signaling regulatory network to elucidate the function of Nrf2 in promoting OS chemoradiotherapy resistance and formulating relevant therapeutic strategies.http://www.sciencedirect.com/science/article/pii/S2352304224001326CarcinogenesisNrf2OsteosarcomaResistanceTherapeutic strategies |
| spellingShingle | Xianglin Peng Jing Feng Han Yang Ping Xia Feifei Pu Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma Genes and Diseases Carcinogenesis Nrf2 Osteosarcoma Resistance Therapeutic strategies |
| title | Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma |
| title_full | Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma |
| title_fullStr | Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma |
| title_full_unstemmed | Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma |
| title_short | Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma |
| title_sort | nrf2 a key regulator in chemoradiotherapy resistance of osteosarcoma |
| topic | Carcinogenesis Nrf2 Osteosarcoma Resistance Therapeutic strategies |
| url | http://www.sciencedirect.com/science/article/pii/S2352304224001326 |
| work_keys_str_mv | AT xianglinpeng nrf2akeyregulatorinchemoradiotherapyresistanceofosteosarcoma AT jingfeng nrf2akeyregulatorinchemoradiotherapyresistanceofosteosarcoma AT hanyang nrf2akeyregulatorinchemoradiotherapyresistanceofosteosarcoma AT pingxia nrf2akeyregulatorinchemoradiotherapyresistanceofosteosarcoma AT feifeipu nrf2akeyregulatorinchemoradiotherapyresistanceofosteosarcoma |